169 related articles for article (PubMed ID: 17124345)
1. Biomarkers indicative of blood-brain barrier disruption in multiple sclerosis.
Waubant E
Dis Markers; 2006; 22(4):235-44. PubMed ID: 17124345
[TBL] [Abstract][Full Text] [Related]
2. Chemokines and matrix metalloproteinase-9 in leukocyte recruitment to the central nervous system.
Sellebjerg F; Sørensen TL
Brain Res Bull; 2003 Aug; 61(3):347-55. PubMed ID: 12909304
[TBL] [Abstract][Full Text] [Related]
3. Spatial diversity of blood-brain barrier alteration and macrophage invasion in experimental autoimmune encephalomyelitis: a comparative MRI study.
Ladewig G; Jestaedt L; Misselwitz B; Solymosi L; Toyka K; Bendszus M; Stoll G
Exp Neurol; 2009 Nov; 220(1):207-11. PubMed ID: 19733560
[TBL] [Abstract][Full Text] [Related]
4. Fatigue and magnetic resonance imaging activity in multiple sclerosis.
Mainero C; Faroni J; Gasperini C; Filippi M; Giugni E; Ciccarelli O; Rovaris M; Bastianello S; Comi G; Pozzilli C
J Neurol; 1999 Jun; 246(6):454-8. PubMed ID: 10431770
[TBL] [Abstract][Full Text] [Related]
5. Blood-brain barrier disruption in multiple sclerosis.
Minagar A; Alexander JS
Mult Scler; 2003 Dec; 9(6):540-9. PubMed ID: 14664465
[TBL] [Abstract][Full Text] [Related]
6. New Enhancing MRI Lesions Associate with IL-17, Neutrophil Degranulation and Integrin Microparticles: Multi-Omics Combined with Frequent MRI in Multiple Sclerosis.
Illes Z; Jørgensen MM; Bæk R; Bente LM; Lauridsen JT; Hyrlov KH; Aboo C; Baumbach J; Kacprowski T; Cotton F; Guttmann CRG; Stensballe A
Biomedicines; 2023 Nov; 11(12):. PubMed ID: 38137391
[TBL] [Abstract][Full Text] [Related]
7. Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment.
Avolio C; Filippi M; Tortorella C; Rocca MA; Ruggieri M; Agosta F; Tomassini V; Pozzilli C; Stecchi S; Giaquinto P; Livrea P; Trojano M
Mult Scler; 2005 Aug; 11(4):441-6. PubMed ID: 16042227
[TBL] [Abstract][Full Text] [Related]
8. How do immune cells overcome the blood-brain barrier in multiple sclerosis?
Larochelle C; Alvarez JI; Prat A
FEBS Lett; 2011 Dec; 585(23):3770-80. PubMed ID: 21550344
[TBL] [Abstract][Full Text] [Related]
9. Viral Infection of the Central Nervous System and Neuroinflammation Precede Blood-Brain Barrier Disruption during Japanese Encephalitis Virus Infection.
Li F; Wang Y; Yu L; Cao S; Wang K; Yuan J; Wang C; Wang K; Cui M; Fu ZF
J Virol; 2015 May; 89(10):5602-14. PubMed ID: 25762733
[TBL] [Abstract][Full Text] [Related]
10. Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis.
Ifergan I; Wosik K; Cayrol R; Kébir H; Auger C; Bernard M; Bouthillier A; Moumdjian R; Duquette P; Prat A
Ann Neurol; 2006 Jul; 60(1):45-55. PubMed ID: 16729291
[TBL] [Abstract][Full Text] [Related]
11. Fingolimod prevents blood-brain barrier disruption induced by the sera from patients with multiple sclerosis.
Nishihara H; Shimizu F; Sano Y; Takeshita Y; Maeda T; Abe M; Koga M; Kanda T
PLoS One; 2015; 10(3):e0121488. PubMed ID: 25774903
[TBL] [Abstract][Full Text] [Related]
12. Central nervous system penetration for small molecule therapeutic agents does not increase in multiple sclerosis- and Alzheimer's disease-related animal models despite reported blood-brain barrier disruption.
Cheng Z; Zhang J; Liu H; Li Y; Zhao Y; Yang E
Drug Metab Dispos; 2010 Aug; 38(8):1355-61. PubMed ID: 20427691
[TBL] [Abstract][Full Text] [Related]
13. [Disruption of the blood-brain barrier in inflammatory neurological diseases].
Shimizu F; Kanda T
Brain Nerve; 2013 Feb; 65(2):165-76. PubMed ID: 23399674
[TBL] [Abstract][Full Text] [Related]
14. Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury.
Rosenberg GA; Dencoff JE; Correa N; Reiners M; Ford CC
Neurology; 1996 Jun; 46(6):1626-32. PubMed ID: 8649561
[TBL] [Abstract][Full Text] [Related]
15. [Blood-brain barrier in multiple sclerosis: mechanisms of its breakdown and repair].
Kanda T
Nihon Rinsho; 2003 Aug; 61(8):1402-8. PubMed ID: 12962030
[TBL] [Abstract][Full Text] [Related]
16. Adhesion molecules and matrix metalloproteinases in Multiple Sclerosis: effects induced by Interferon-beta.
Avolio C; Giuliani F; Liuzzi GM; Ruggieri M; Paolicelli D; Riccio P; Livrea P; Trojano M
Brain Res Bull; 2003 Aug; 61(3):357-64. PubMed ID: 12909305
[TBL] [Abstract][Full Text] [Related]
17. Inflammation and brain edema: new insights into the role of chemokines and their receptors.
Stamatovic SM; Dimitrijevic OB; Keep RF; Andjelkovic AV
Acta Neurochir Suppl; 2006; 96():444-50. PubMed ID: 16671502
[TBL] [Abstract][Full Text] [Related]
18. Endothelial Wnt/β-catenin signaling reduces immune cell infiltration in multiple sclerosis.
Lengfeld JE; Lutz SE; Smith JR; Diaconu C; Scott C; Kofman SB; Choi C; Walsh CM; Raine CS; Agalliu I; Agalliu D
Proc Natl Acad Sci U S A; 2017 Feb; 114(7):E1168-E1177. PubMed ID: 28137846
[TBL] [Abstract][Full Text] [Related]
19. Multiple sclerosis: elevated expression of matrix metalloproteinases in blood monocytes.
Kouwenhoven M; Ozenci V; Gomes A; Yarilin D; Giedraitis V; Press R; Link H
J Autoimmun; 2001 Jun; 16(4):463-70. PubMed ID: 11437495
[TBL] [Abstract][Full Text] [Related]
20. Disruption of central nervous system barriers in multiple sclerosis.
Alvarez JI; Cayrol R; Prat A
Biochim Biophys Acta; 2011 Feb; 1812(2):252-64. PubMed ID: 20619340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
